The Lancet. Oncology | Journament

Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Sign In to Calculate Scores Authentication required

The Lancet. Oncology

Login or register to claim ownership or editorship of this journal.
Indexings
Short Name The Lancet. Oncology
Abbreviated Name The Lancet. Oncology
ISSN 1474-5488
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (2 total)

2021
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
Dimopoulos MA;Terpos E;Boccadoro M;Delimpasi S;Beksac M;Katodritou E;Moreau P;Baldini L;Symeonidis A;Bila J;Oriol A;Mateos MV;Einsele H;Orfanidis I;Ahmadi T;Ukropec J;Kampfenkel T;Schecter JM;Qiu Y;Amin H;Vermeulen J;Carson R;Sonneveld P; ;;
Vol. 22 , No. 6 , pp. -
362 views Abstract
2015
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
Gay F;Oliva S;Petrucci MT;Conticello C;Catalano L;Corradini P;Siniscalchi A;Magarotto V;Pour L;Carella A;Malfitano A;Petrò D;Evangelista A;Spada S;Pescosta N;Omedè P;Campbell P;Liberati AM;Offidani M;Ria R;Pulini S;Patriarca F;Hajek R;Spencer A;Boccadoro M;Palumbo A;;
Vol. 16 , No. 16 , pp. -
266 views Abstract
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0
Journament